Antibody blockade of Thy-1 (CD90) impairs mouse cytotoxic T lymphocyte induction by anti-CD3 monoclonal antibody

Immunology and Cell Biology

Volumn 83, Issue 4, 2005, Pages 352-363

  Haeryfar, S M Mansour ^a   Conrad, David M ^a   Musgrave, Bruce L ^a   Hoskin, David W ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Costimulation; Cytokine; Cytotoxicity; Signal transduction; T lymphocyte; Thy 1

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; FAS LIGAND; GRANZYME B; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY CD3; PERFORIN; PHORBOL ESTER; POLYSTYRENE; PROTEIN KINASE C; THY 1 ANTIGEN;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TARGET CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION; ANTIGENS, THY-1; CELL PROLIFERATION; ENDOPEPTIDASES; GENE EXPRESSION REGULATION; GRANZYMES; INTERLEUKIN-2; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; PORE FORMING CYTOTOXIC PROTEINS; PROTEIN KINASE C; RECEPTORS, INTERLEUKIN-2; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC;

EID: 22944467850     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2005.01342.x     Document Type: Article

References (38)

1. Haeryfar SMM, Hoskin DW. Thy-1: more than a mouse pan-T cell marker. J. Immunol. 2004; 173: 3581-8.
2. Romagnoli P, Bron C. Phosphatidylinositol-based glycolipid-anchored proteins enhance proximal TCR signaling events. J. Immunol. 1997; 158: 5757-64.
3. Beissert S, He HT, Hueber AO et al. Impaired cutaneous immune responses in Thy-1-deficient mice. J. Immunol. 1998; 161: 5296-302.
4. De Mello Coelho V, Nguyen D, Giri B, Bunbury A, Schaffer E, Taub DD. Quantitative differences in lipid raft components between murine CD4+ and CD8+ T cells. BMC Immunol. 2004; 5: 2-9.
5. Haeryfar SMM, Al-alwan MM, Mader JS, Rowden G, West KA, Hoskin DW. Thy-1 signaling in the context of costimulation provided by dendritic cells provides signal 1 for T cell proliferation and cytotoxic effector molecule expression, but fails to trigger delivery of the lethal hit. J. Immunol. 2003; 171: 69-77.
6. Gunter KC, Germain RN, Kroczek RA et al. Thy-1-mediated T-cell activation requires co-expression of CD3/Ti complex. Nature 1987; 326: 505-7.
7. Killeen N. T-cell regulation: Thy-1 - hiding in full view. Curr. Biol. 1997; 7: R774-7.
8. Ilangumaran S, He HT, Hoessli DC. Microdomains in lymphocyte signalling: beyond GPI-anchored proteins. Immunol. Today 2000; 21: 2-7.
9. Leyton L, Quest AF, Bron C. Thy-1/CD3 coengagement promotes TCR signaling and enhances particularly tyrosine phosphorylation of the raft molecule LAT. Mol. Immunol. 1999; 36: 755-68.
10. Johnson R, Lancki DW, Fitch FW. Accessory molecules involved in antigen-mediated cytolysis and lymphokine production by cytotoxic T lymphocyte subsets. I. Identification of functions for the T cell surface molecules Ly-6C and Thy-1. J. Immunol. 1993; 151: 2986-99.
11. Ledbetter JA, Herzenberg LA. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 1979; 47: 63-90.
12. Marakovsky E, Chen W-F, Shortman K. IL-2 and IFN-γ are two necessary lymphokines in the development of cytotoxic T cells. J. Immunol. 1989; 143: 1210-14.
13. Okamoto T, Harada M, Shinomiya Y, Matsuzaki G, Nomoto K. The antitumor effect of tumor-draining lymph node cells activated by both anti-CD3 monoclonal antibody and activated B cells as costimulatory-signal-providing cells. Cancer Immunol. Immunother. 1995; 40: 173-81.
14. Singer-Sam J, Robinson MO, Bellve AR, Simon MI, Riggs AD. Measurement by quantitative PCR of changes in HPRT, PGK-1, PGK-2, APRT, MTase, and Zfy gene transcripts during mouse spermatogenesis. Nucleic Acids Res. 1990; 18: 1255-9.
15. Makrigiannis AP, Musgrave BL, Hoskin DW. Differential effects of B7-1 and B7-2 on the costimulation of mouse non-specific cytotoxic T lymphocyte development in response to anti-CD3 antibody. J. Leukoc. Biol. 1999; 66: 792-802.
16. Hathcock KS, Laszlo G, Pucillo C, Linsley P, Modes RJ. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 1994; 180: 631-40.
17. Hoskin DW, Williams B, Fitzpatrick L, Makrigiannis AP. Cell biology and possible therapeutic applications of anti-CD3-activated killer-T cells. Int. J. Mol. Med. 1998; 1: 893-902.
18. Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 2002; 20: 323-70.
19. Makrigiannis AP, Hoskin DW. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity. J. Immunol. 1997; 159: 4700-7.
20. Kataoka T, Shinohara N, Takayama H et al. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J. Immunol. 1996; 156: 3678-86.
21. Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell 1994; 76: 263-74.
22. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 1996; 14: 233-58.
23. Musgrave BL, Watson CL, Haeryfar SMM, Barnes CA, Hoskin DW. CD2-CD48 interactions promote interleukin-2 and interferon-γ synthesis by stabilizing cytokine mRNA. Cell. Immunol. 2004; 229: 1-12.
24. Yashiro Y, Tai X-G, Toyo-oka K et al. A fundamental difference in the capacity to induce proliferation of naïve T cells between CD28 and other co-stimulatory molecules. Eur. J. Immunol. 1998; 28: 926-35.
25. Dustin ML, Shaw AS. Costimulation: building an immunological synapse. Science 1999; 283: 649-50.
26. Miceli MC, Moran M, Chung CD, Patel VP, Low T, Zinnanti W. Co-stimulation and counter-stimulation: lipid raft clustering controls TCR signaling and functional outcomes. Semin. Immunol. 2001; 13: 115-28.
27. Wu Y, Guo Y, Janeway CA, Liu Y. Signaling by a new anti-Thy 1 monoclonal antibody inhibits T cell proliferation and interferes with T-cell-mediated induction of costimulatory molecule B7-2. Cell. Immunol. 1995; 165: 266-77.
28. Leyton L, Schneider P, Labra CV et al. Thy-1 binds to integrin β3 on astrocytes and triggers formation of focal contact sites. Curr. Biol. 2001; 11: 1028-38.
29. Wetzel A, Chavakis T, Preissner KT et al. Human Thy-1 (CD90) on activated endothelial cells is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J. Immunol. 2004; 172: 3850-9.
30. Ranheim EA, Kipps TJ. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 1993; 177: 925-35.
31. Huang J, Lo PF, Zal T et al. CD28 plays a critical role in the segregation of PKC theta within the immunologic synapse. Proc. Natl. Acad. Sci. USA 2002; 99: 9369-73.
32. Isakov N, Altman A. Protein kinase C (θ) in T cell activation. Annu. Rev. Immunol. 2002; 20: 761-94.
33. Williams BA, Makrigiannis AP, Blay J, Hoskin DW. Treatment of the P815 murine mastocytoma with cisplatin or etoposide up-regulates cell-surface Fas (CD95) expression and increases sensitivity to anti-Fas antibody-mediated cytotoxicity and to lysis by anti-CD3-activated killer-T cells. Int. J. Cancer 1997; 73: 416-23.
34. Vignaux F, Vivier E, Malissen B, Depraetere V, Nagata S, Golstein P. TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 1995; 181: 781-6.
35. Liu CC, Rafii S, Granelli-Piperno A, Trapani JA, Young JD. Perforin and serine esterase gene expression in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A. J. Exp. Med. 1989; 170: 2105-18.
36. Marmor MD, Julius M. Role for lipid rafts in regulating interleukin-2 receptor signaling. Blood 2001; 98: 1489-97.
37. Clark WR, Walsh CM, Glass AA, Huang MT, Ahmed R, Matloubian M. Cell-mediated cytotoxicity in perforin-less mice. Int. Rev. Immunol. 1995; 13: 1-14.
38. Chouaib S, Chehimi J, Bani L et al. Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors. Proc. Natl. Acad. Sci. USA 1994; 91: 12659-63.